REMS medications are drugs that the U.S. Food and Drug Administration requires to carry extra safety controls to manage serious risks. Think of them as products sold with special safety rules—such as restricted distribution, mandatory training for prescribers, or close patient monitoring—that reduce harm but can limit how easily the drug reaches patients. For investors, REMS status can affect sales growth, supply logistics, compliance costs and legal exposure, making a drug's market potential more complex to assess.
pseudoephedrinemedical
A common over‑the‑counter nasal decongestant found in cold and allergy medicines that shrinks swollen blood vessels in the nose to relieve congestion. It matters to investors because its legal status, sales rules, and supply chain controls (driven by its misuse as a precursor for illegal drugs) can affect product availability, retail revenue, regulatory risk, and costs for manufacturers and pharmacies—similar to how a safety recall could change demand and margins.
medicare part bregulatory
Medicare Part B is the U.S. government health insurance program that pays for outpatient care, doctor visits, certain medical tests, and durable medical equipment for enrolled beneficiaries. It matters to investors because Part B sets payment rules and prices that drive revenue for hospitals, clinics, drugmakers and medical device companies, so changes in coverage, reimbursement rates or enrollment levels can directly affect those companies’ earnings—think of it as a large, rules-driven customer that decides how much it will pay.
compound drugsmedical
Compound drugs are medicines that pharmacists create by mixing, altering, or combining ingredients to meet a specific patient's needs—think of a tailor making a custom suit instead of selling off-the-rack clothing. They matter to investors because this niche can offer differentiated revenue, higher margins, and customer stickiness, but it also carries distinct supply, quality and regulatory risks that can affect a company’s growth and legal exposure.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
Customers can pick up eligible prescriptions curbside through DriveUp & Go™; new pharmacy customers may be eligible for grocery savings
BOISE, Idaho--(BUSINESS WIRE)--
Albertsons® Companies, Inc. (NYSE: ACI) today announced the nationwide expansion of its free curbside pickup service DriveUp & Go™ to include free curbside pickup for eligible pharmacy prescriptions*, giving customers a simple way to get the medications they need without waiting in line or leaving their vehicle. Available at more than 1,700 participating store and pharmacy locations, the service adds another easy option designed to help customers save time and manage their health in the flow of everyday life.
“At Albertsons Cos., our focus is making health care simpler and more convenient for the customers we serve,” said Anthony DalPonte, President of Pharmacy and Health at Albertsons Cos. “Adding prescription pickup to DriveUp & Go removes friction, saves time and gives customers greater flexibility as they manage their health and wellness needs, reinforcing our commitment to a customer‑centered pharmacy experience.”
DriveUp & Go prescription pickup allows customers to skip the pharmacy line and conveniently receive eligible medications curbside. Customers can place orders online or through the Albertsons Cos. store app, select a pickup time during designated pharmacy DriveUp & Go hours and prepay in advance. Upon arrival, prescriptions are delivered directly to the customer’s vehicle. Prescription pickup can be added to a grocery DriveUp & Go order as well, though no grocery purchase is required.
To welcome new pharmacy customers, Albertsons Cos. also offers grocery savings incentives. Eligible customers who fill or transfer prescriptions to an Albertsons Cos. pharmacy for the first time can earn savings off groceries.†
For more information about DriveUp & Go prescription pickup, including eligibility and participating locations, or the grocery savings incentive for new pharmacy customers, visit the Pharmacy section of your Albertsons Cos. store website or app.
*Not all prescriptions are eligible for DriveUp & Go, including refrigerated or frozen medications, first fills of controlled medications, REMS medications, pseudoephedrine, compound drugs and glucose testing supplies billed to Medicare Part B.
Albertsons Companies is a leading food and drug retailer in the United States. As of Feb. 28, 2026, the Company operated 2,244 retail food and drug stores with 1,713 in-store pharmacies, 405 associated fuel centers, 22 dedicated distribution centers and 19 manufacturing facilities. The Company operates stores across 35 states and the District of Columbia under 22 well known banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw's, ACME, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen, Carrs, Kings Food Markets and Balducci's Food Lovers Market. The Company is committed to helping people across the country live better lives by making a meaningful difference, neighborhood by neighborhood. In 2025, along with the Albertsons Companies Foundation, the Company contributed $497 million in food and financial support, including $56 million through its Nourishing Neighbors Program to ensure those living in its communities and those impacted by disasters have enough to eat.
Albertsons, Safeway, Vons, Jewel-Osco, Tom Thumb, Randalls, United Supermarkets, Pavilions, Haggen and Balducci's Food Lovers Market are registered trademarks of Albertsons Companies Inc. or its subsidiaries. ACME, Carrs, Kings Food Markets, Shaw's and Star Market are trademarks of Albertsons Companies Inc. or its subsidiaries. Albertsons associated logos, product names and services are trademarks of Albertsons Companies, Inc. All other trademarks are the property of their respective owners.
